June 2012 Editor's Picks: Products from EMD Millipore and Meissner Filtration Products - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

June 2012 Editor's Picks: Products from EMD Millipore and Meissner Filtration Products

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

EMD Millipore
Single-use bioreactor is designed for process development or pilot-scale cell culture

EMD Millipore’s Mobius CellReady 50-L single-use, stirred tank bioreactor is designed for process development and pilot-scale mammalian cell culture. The rigid base and top panel design of the bioreactor process container enables simple, reliable, and robust one-way installation. Mobius SensorReady technology allows the user to configure process monitoring at the point of use and enables integration of new sensor technologies. The system is available as a turnkey solution complete with Finesse automation or as modules that can be integrated with the customer’s platform of choice.


Meissner Filtration Products
Containers support disposable biocontainer assemblies

Meissner Filtration Products’ QuaDrum containers for Meissner’s TepoFlex 3D biocontainer assemblies have a square design rather than the industry standard cylindrical design.  The design makes efficient use of floor space, and can be used with a stainless steel dolly for intra-facility transport. The reusable, polyethylene containers are chemically resistant and can be sanitized. Slotted lids offer access to tubing and filters or solid lids completely cover the assembly.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Equipment and Processing Report,
Click here